{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:21:37Z","timestamp":1771615297747,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"DOI":"10.1007\/s12308-026-00686-6","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T18:34:32Z","timestamp":1771612472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Morphologic findings and mutational profiles of myelodysplastic neoplasms with normal versus abnormal karyotype"],"prefix":"10.1007","volume":"19","author":[{"given":"Jyoti","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandria","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Stehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Spinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Fernandez-Pol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter L.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"686_CR1","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, Revised","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL et al (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, Revised, 4th edn. International Agency for Research on Cancer, Lyon","edition":"4"},{"key":"686_CR2","unstructured":"WHO Classification of Tumours Online. https:\/\/tumourclassification.iarc.who.int\/ chaptercontent\/63"},{"key":"686_CR3","volume-title":"The international consensus classification of myeloid and lymphoid neoplasms","author":"DA Arber","year":"2025","unstructured":"Arber DA (2025) The international consensus classification of myeloid and lymphoid neoplasms. LWW, Philadelphia"},{"key":"686_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/leu.2010.293","volume":"25","author":"A Thiel","year":"2011","unstructured":"Thiel A, Beier M, Ingenhag D et al (2011) Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevance. Leukemia 25:387\u2013399. https:\/\/doi.org\/10.1038\/leu.2010.293","journal-title":"Leukemia"},{"key":"686_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/leu.2013.336","volume":"28","author":"T Haferlach","year":"2014","unstructured":"Haferlach T, Nagata Y, Grossmann V et al (2014) Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 28:241\u2013247. https:\/\/doi.org\/10.1038\/leu.2013.336","journal-title":"Leukemia"},{"key":"686_CR6","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1056\/NEJMra1904794","volume":"383","author":"M Cazzola","year":"2020","unstructured":"Cazzola M (2020) Myelodysplastic syndromes. N Engl J Med 383:1358\u20131374. https:\/\/doi.org\/10.1056\/NEJMra1904794","journal-title":"N Engl J Med"},{"key":"686_CR7","doi-asserted-by":"publisher","unstructured":"Bernard E, Tuechler H, Greenberg PL et al (2022) Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM Evidence 1. https:\/\/doi.org\/10.1056\/EVIDoa2200008","DOI":"10.1056\/EVIDoa2200008"},{"key":"686_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2023.107433","volume":"136","author":"V Khanna","year":"2024","unstructured":"Khanna V, Lu R, Kumar J et al (2024) The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms. Leuk Res 136:107433. https:\/\/doi.org\/10.1016\/j.leukres.2023.107433","journal-title":"Leuk Res"},{"key":"686_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jmoldx.2017.10.007","volume":"20","author":"S-R Yang","year":"2018","unstructured":"Yang S-R, Lin C-Y, Stehr H et al (2018) Comprehensive genomic profiling of malignant effusions in patients with metastatic lung adenocarcinoma. J Mol Diagn 20:184\u2013194. https:\/\/doi.org\/10.1016\/j.jmoldx.2017.10.007","journal-title":"J Mol Diagn"},{"key":"686_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01480-y","volume":"16","author":"W Bahaj","year":"2023","unstructured":"Bahaj W, Kewan T, Gurnari C et al (2023) Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia. J Hematol Oncol 16:91. https:\/\/doi.org\/10.1186\/s13045-023-01480-y","journal-title":"J Hematol Oncol"},{"key":"686_CR11","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/s41591-020-1008-z","volume":"26","author":"E Bernard","year":"2020","unstructured":"Bernard E, Nannya Y, Hasserjian RP et al (2020) Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes. Nat Med 26:1549\u20131556. https:\/\/doi.org\/10.1038\/s41591-020-1008-z","journal-title":"Nat Med"},{"key":"686_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3324\/haematol.2012.071449","volume":"98","author":"L Senent","year":"2013","unstructured":"Senent L, Arenillas L, Luno E et al (2013) Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes. Haematologica 98:568\u2013575. https:\/\/doi.org\/10.3324\/haematol.2012.071449","journal-title":"Haematologica"},{"key":"686_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1046\/j.1365-2141.1996.d01-1786.x","volume":"94","author":"BJ Bain","year":"1996","unstructured":"Bain BJ (1996) The bone marrow aspirate of healthy subjects. Br J Haematol 94:206\u2013209. https:\/\/doi.org\/10.1046\/j.1365-2141.1996.d01-1786.x","journal-title":"Br J Haematol"},{"key":"686_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3324\/haematol.2011.056879","volume":"97","author":"S Parmentier","year":"2012","unstructured":"Parmentier S, Schetelig J, Lorenz K et al (2012) Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors. Haematologica 97:723\u2013730. https:\/\/doi.org\/10.3324\/haematol.2011.056879","journal-title":"Haematologica"},{"key":"686_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/leu.2014.161","volume":"29","author":"MG Della Porta","year":"2015","unstructured":"Della Porta MG, Travaglino E, Boveri E et al (2015) Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes. Leukemia 29:66\u201375. https:\/\/doi.org\/10.1038\/leu.2014.161","journal-title":"Leukemia"},{"key":"686_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.leukres.2012.02.014","volume":"36","author":"U Germing","year":"2012","unstructured":"Germing U, Strupp C, Giagounidis A et al (2012) Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the D\u00fcsseldorf registry on myelodysplastic syndromes. Leuk Res 36:727\u2013734. https:\/\/doi.org\/10.1016\/j.leukres.2012.02.014","journal-title":"Leuk Res"},{"key":"686_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1182\/blood-2015-03-633537","volume":"126","author":"L Malcovati","year":"2015","unstructured":"Malcovati L, Karimi M, Papaemmanuil E et al (2015) SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood 126:233\u2013241. https:\/\/doi.org\/10.1182\/blood-2015-03-633537","journal-title":"Blood"},{"key":"686_CR18","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41375-018-0351-2","volume":"33","author":"D Haase","year":"2019","unstructured":"Haase D, Stevenson KE, Neuberg D et al (2019) TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Leukemia 33:1747\u20131758. https:\/\/doi.org\/10.1038\/s41375-018-0351-2","journal-title":"Leukemia"},{"key":"686_CR19","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","volume":"364","author":"R Bejar","year":"2011","unstructured":"Bejar R, Stevenson K, Abdel-Wahab O et al (2011) Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med 364:2496\u20132506","journal-title":"N Engl J Med"},{"key":"686_CR20","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1182\/bloodadvances.2025016897","volume":"9","author":"WJ Wong","year":"2025","unstructured":"Wong WJ, Zon RL, Gibson CJ et al (2025) Somatic mutations in STAG2 are associated with separated megakaryocyte nuclear lobes in myelodysplastic syndromes. Blood Adv 9:5283\u20135288. https:\/\/doi.org\/10.1182\/bloodadvances.2025016897","journal-title":"Blood Adv"},{"key":"686_CR21","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3324\/haematol.2017.181842","volume":"103","author":"OK Weinberg","year":"2018","unstructured":"Weinberg OK, Gibson CJ, Blonquist TM et al (2018) Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO classification-defined cytogenetic abnormalities. Haematologica 103:626\u2013633. https:\/\/doi.org\/10.3324\/haematol.2017.181842","journal-title":"Haematologica"},{"key":"686_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-021-00606-3","volume":"6","author":"X Zeng","year":"2021","unstructured":"Zeng X, Zhang Y, Zhao K et al (2021) Somatic mutations predict prognosis in myelodysplastic syndrome patients with normal karyotypes. Sig Transduct Target Ther 6:1\u20133. https:\/\/doi.org\/10.1038\/s41392-021-00606-3","journal-title":"Sig Transduct Target Ther"},{"key":"686_CR23","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.3324\/haematol.2022.282528","volume":"108","author":"VT Quang","year":"2023","unstructured":"Quang VT, Podvin B, Desterke C et al (2023) TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia. Haematologica 108:3135\u20133141. https:\/\/doi.org\/10.3324\/haematol.2022.282528","journal-title":"Haematologica"},{"key":"686_CR24","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1038\/s41375-022-01733-8","volume":"36","author":"N Garcia-Gisbert","year":"2022","unstructured":"Garcia-Gisbert N, Arenillas L, Roman-Bravo D et al (2022) Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia. Leukemia 36:2922\u20132926. https:\/\/doi.org\/10.1038\/s41375-022-01733-8","journal-title":"Leukemia"},{"key":"686_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1182\/bloodadvances.2018024216","volume":"3","author":"H Awada","year":"2019","unstructured":"Awada H, Nagata Y, Goyal A et al (2019) Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia. Blood Adv 3:339\u2013349. https:\/\/doi.org\/10.1182\/bloodadvances.2018024216","journal-title":"Blood Adv"},{"key":"686_CR26","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1182\/blood.2023023727","volume":"144","author":"E Bernard","year":"2024","unstructured":"Bernard E, Hasserjian RP, Greenberg PL et al (2024) Molecular taxonomy of myelodysplastic syndromes and its clinical implications. Blood 144:1617\u20131632. https:\/\/doi.org\/10.1182\/blood.2023023727","journal-title":"Blood"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00686-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-026-00686-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00686-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T18:34:34Z","timestamp":1771612474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-026-00686-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["686"],"URL":"https:\/\/doi.org\/10.1007\/s12308-026-00686-6","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the requirements of Stanford University\u2019s Institutional Review Board (IRB). This article does not contain any studies with animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study was reviewed by Stanford University\u2019s Institutional Review Board (IRB), and the need for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"6"}}